Insider trades
David Kirn, Officer of 4D Molecular Therapeutics FDMT, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 06/22.
David Kirn
SEE REMARKS
- First filing
- 23/01/23
- Trades
- 28 trades
- Buys / sales
- 0 / 16
- 12-month net buying
- −$1.2M
- Last trade
- 06/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/22 | 06/23 | 114,746 sh | $10.47 | $1,201,390.62 | −10.9% | |
| Open-market sale10b5-1 plan | 06/01 | 06/02 | 1,922 sh | $10.02 | $19,258.44 | −0.2% | |
| Open-market sale10b5-1 plan | 24/07/10 | 24/07/12 | 12,923 sh | $22.49 | $290,638.27 | −1.2% | |
| Open-market sale10b5-1 plan | 24/06/24 | 24/06/26 | 12,930 sh | $23.10 | $298,683 | −1.2% | |
| Open-market sale10b5-1 plan | 24/02/08 | 24/02/12 | 92,001 sh | $27.13 | $2,495,987.13 | −8.0% | |
| Open-market sale | 24/01/23 | 24/01/25 | 5,696 sh | $18.41 | $104,863.36 | −0.5% | |
FDMT | Open-market sale10b5-1 plan | 23/12/15–24/01/05 | 24/01/08 | 102,303 sh5 trades | $19.15avg. | $1,959,377.69 | −8.1% |
FDMT | Open-market sale | 23/02/21–23/02/22 | 23/02/23 | 34,446 sh3 trades | $20.61avg. | $709,783.91 | −1.8% |
FDMT | Open-market sale | 23/01/19–23/01/20 | 23/01/23 | 19,524 sh2 trades | $20.10avg. | $392,445.72 | −1.0% |